Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail

被引:75
作者
Pak, Y
ODowd, BF
George, SR
机构
[1] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON M5S 1A8,CANADA
[2] UNIV TORONTO,DEPT MED,TORONTO,ON M5S 1A8,CANADA
[3] ADDICT RES FDN,TORONTO,ON M5S 2S1,CANADA
关键词
D O I
10.1074/jbc.272.40.24961
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To identify the structural determinants necessary for mu opioid receptor desensitization, we serially ablated potential phosphorylation sites in the carboxyl tail of the receptor and examined their effects on [D-Ala(2),N-Me-Phe(4),Gly-ol(5)]lenkephalin (DAMGO)-induced desensitization, First, we replaced Thr(394) with alanine (T394A) and stably expressed this mutant receptor in Chinese hamster ovary cells, The T394A receptor did not desensitize after 1 h of treatment with DAMGO, indicating that Thr(394) is required for agonist-induced early desensitization, To test whether Thr(394) was the only residue necessary, we investigated the importance of 7 potential phosphorylation sites between residues 363 and 383, which were all replaced by alanines with the Thr(394) maintained, This mutant (AT) showed partial loss of desensitization (30%), which was attributable to the Ala mutation at Thr(383), since complete desensitization was achieved by restoring Thr(383) (ATT), These results suggest that Thr(394) is the primary recognition site for G protein-coupled receptor kinases, but Thr(383) is also required for complete agonist-induced desensitization. The specificity of Thr(394) as the primary initiation site appears to be dependent on the preceding acidic amino acid stretch, because in a mutant in which glutamic acid residues at 388, 391, and 393 were replaced by glutamines (EQ), agonist-induced desensitization was completely abolished, identical to the T394A mutant.
引用
收藏
页码:24961 / 24965
页数:5
相关论文
共 36 条
[1]  
BARTON AC, 1990, MOL PHARMACOL, V38, P531
[2]  
BARTON AC, 1991, MOL PHARMACOL, V39, P650
[3]  
BATES MD, 1991, MOL PHARMACOL, V39, P55
[4]  
BLAXALL HS, 1994, MOL PHARMACOL, V45, P176
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   MECHANISMS OF RHODOPSIN INACTIVATION IN-VIVO AS REVEALED BY A COOH-TERMINAL TRUNCATION MUTANT [J].
CHEN, J ;
MAKINO, CL ;
PEACHEY, NS ;
BAYLOR, DA ;
SIMON, MI .
SCIENCE, 1995, 267 (5196) :374-377
[7]  
CHEN Y, 1994, J BIOL CHEM, V269, P7839
[8]   4 CONSECUTIVE SERINES IN THE 3RD INTRACELLULAR LOOP ARE THE SITES FOR BETA-ADRENERGIC-RECEPTOR KINASE-MEDIATED PHOSPHORYLATION AND DESENSITIZATION OF THE ALPHA(2A)-ADRENERGIC RECEPTOR [J].
EASON, MG ;
MOREIRA, SP ;
LIGGETT, SB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4681-4688
[9]   Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta(2)-adrenergic receptor [J].
Fredericks, ZL ;
Pitcher, JA ;
Lefkowitz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) :13796-13803
[10]   SPECIES AND AGE-DEPENDENT DIFFERENCES OF FUNCTIONAL COUPLING BETWEEN OPIOID DELTA-RECEPTOR AND G-PROTEINS AND POSSIBLE INVOLVEMENT OF PROTEIN-KINASE-C IN STRIATAL MEMBRANES [J].
FUKUSHIMA, N ;
UEDA, H ;
HAYASHI, C ;
KATAYAMA, T ;
MIYAMAE, T ;
MISU, Y .
NEUROSCIENCE LETTERS, 1994, 176 (01) :55-58